Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Xi_Chen
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
gene editing
genome engineering |
| gptkbp:foundedYear |
2021
|
| gptkbp:fundedBy |
$213 million
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tome Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Andreessen_Horowitz
gptkb:Arch_Venture_Partners gptkb:GV_(Google_Ventures) gptkb:Longwood_Fund |
| gptkbp:mission |
develop curative genomic medicines
|
| gptkbp:technology |
gene insertion
programmable genomic integration |
| gptkbp:website |
https://www.tome.bio/
|
| gptkbp:bfsParent |
gptkb:Fine_Structure_Ventures
gptkb:a16z_Bio |
| gptkbp:bfsLayer |
7
|